ACE inhibitor-induced angioedema
- PMID: 22127615
 - DOI: 10.1007/s11882-011-0238-z
 
ACE inhibitor-induced angioedema
Abstract
Much has been written about hereditary angioedema (HAE) in recent literature; however, the prevalence of angiotensin-converting enzyme inhibitor-induced angioedema (ACEiIA) far exceeds that of HAE. Similarly, multiple therapies have been developed for HAE, yet no definitive therapy is available for ACEiIA. In this article, we discuss the mechanism, prevalence, pathophysiology, and management of ACEiIA, with focus on newer therapies recently approved for HAE and how they may be effective for ACEiIA.
References
- 
    
- Curr Opin Allergy Clin Immunol. 2010 Feb;10(1):20-5 - PubMed
 
 - 
    
- Clin J Am Soc Nephrol. 2010 Apr;5(4):703-8 - PubMed
 
 - 
    
- Acta Anaesthesiol Scand. 2006 Jan;50(1):120-2 - PubMed
 
 - 
    
- J Investig Allergol Clin Immunol. 2011;21(5):333-47; quiz follow 347 - PubMed
 
 - 
    
- Biochem Biophys Res Commun. 2003 Jul 11;306(4):981-7 - PubMed
 
 
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
